Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/25/2004 | CN1522706A Preparation of solid dispersoid containing large ring lactone parasite medicine |
08/25/2004 | CN1522705A Pharmaceutical for treating cardiovascular and cerebrovascular disease |
08/25/2004 | CN1522704A Parasite resistant slow release injection formulation for animals |
08/25/2004 | CN1522702A Slow and control release aspirin capsule formulation and method for making same |
08/25/2004 | CN1522700A Furfuryl sterol drop pills and method for making same |
08/25/2004 | CN1522697A Prevention of migraine recurrence |
08/25/2004 | CN1522695A Indapamide slow release capsule and preparation method |
08/25/2004 | CN1522694A Medicine for treating dizziness and making method thereof |
08/25/2004 | CN1522693A Sodium ferulic acid osmosis pump controlled release formulation and its preparation method |
08/25/2004 | CN1522692A Pressurized metered dose inhalers and pharmaceutical aerosol fomulations |
08/25/2004 | CN1522691A Nucleic acid, protein polypeptide and vaccine emulsion preparation method |
08/25/2004 | CN1522687A Oral health product using adhesive material as carrier |
08/25/2004 | CN1522590A Separate nutrient content granulating capsule production method of mixed feed for livestock and fowl |
08/25/2004 | CN1163377C Method of manufacturing adhesive plaster |
08/25/2004 | CN1163288C Process for manufacture of amorphous products by means of convection drying |
08/25/2004 | CN1163275C Biofunctional polymers prepared in supercritical fluid |
08/25/2004 | CN1163274C Molded articles and method of producing the same |
08/25/2004 | CN1163265C Pharmaceutical formulations of nerve growth factor |
08/25/2004 | CN1163264C Pharmaceutical compositions |
08/25/2004 | CN1163263C Polypeptide medicine as oral spray |
08/25/2004 | CN1163260C Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides |
08/25/2004 | CN1163256C Chinese herb medicine composition for curing chronic colitis, gastritis and gastric ulcer |
08/25/2004 | CN1163255C Hyperosteogeny treating plaster |
08/25/2004 | CN1163243C Prepared pill of traditional Chinese medicine for treating hepatism |
08/25/2004 | CN1163242C Heart nourishing capsule and its preparing process |
08/25/2004 | CN1163241C psoriasis medicine and preparation method |
08/25/2004 | CN1163233C Intra-cancer-cell nuclease activator |
08/25/2004 | CN1163232C Fatty emulsing containing reducing sugar and method for sterilizing same |
08/25/2004 | CN1163231C Novel galanic formulation of meloxicam for oral administration |
08/25/2004 | CN1163223C Preparation capable of releasing drug at target in intestine |
08/25/2004 | CN1163222C Drug delivery system for releasing two or more active substance |
08/25/2004 | CN1163221C Pharmaceutical flavours masking agent powder |
08/25/2004 | CN1163220C Tablet for instant and prolonged release of one or more active substances |
08/25/2004 | CN1163219C First aid adhesive plaster |
08/25/2004 | CN1163214C Hair caring use of euonymus plant extract |
08/25/2004 | CN1163212C Apparatus for orienting and positioning elongate object for dispensing |
08/25/2004 | CN1163125C Solution and process for resuscitation and reparation of ischemically damaged tissue |
08/25/2004 | CA2448955A1 Fluid-jet pens configured for making modulated release bioactive agents |
08/24/2004 | US6782307 Method for producing customized cosmetic and pharmaceutical formulations on demand |
08/24/2004 | US6780889 Prepared by mixing gamma-hydroxybutyrate and a ph-adjusting agent in an aqueous medium |
08/24/2004 | US6780882 Substituted benzimidazole dosage forms and method of using same |
08/24/2004 | US6780881 Freeze-dried pantoprazole preparation and pantoprazole injection |
08/24/2004 | US6780849 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing s-n=o, n-n=o or |
08/24/2004 | US6780846 Membrane translocating peptide drug delivery system |
08/24/2004 | US6780838 Compounds for treating fungal pathologies of the oral cavity |
08/24/2004 | US6780628 Enzyme treatment |
08/24/2004 | US6780508 Powder particles with smooth surface for use in inhalation therapy |
08/24/2004 | US6780507 Extruding liquid core with polymerizable liquid through concentric nozzles forming droplets, then heating to polymerize outer layer; useful as artificial diet capsules in beneficial insect rearing; biological pest control |
08/24/2004 | US6780504 Covering, active material and adhesive; spraying |
08/24/2004 | US6780437 Coated potassium chloride granules and tablets |
08/24/2004 | US6780436 Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound |
08/24/2004 | US6780435 Pellet comprising inert core component, omeprazole, surface active agent, filler, alkaline agent, binder and single layer of enteric coating |
08/24/2004 | US6780434 Controlled release of metal cation-stabilized interferon |
08/24/2004 | US6780433 Using high-shear aqueous wet granulation with fluid-bed drying to form tablets of olanzapine having polymer coating; stability and prevents discoloration; for treatment of schizophrenia, mild anxiety, gastrointestinal disorders, and |
08/24/2004 | US6780432 Composed of such as metformin and having pioglitazone hydrochloride coating; synergistic controlled release action in single dosage |
08/24/2004 | US6780430 Stabilzation method of nano-sized emulsion using tocopheryl derivatives and external application for skin containing the same |
08/24/2004 | US6780429 With 2'-5' phosphodiester bond content up to 3%; maintains pharmacological action while reducing toxicity |
08/24/2004 | US6780428 Loaded drugs can be physically retained in the micelles when the ph of the surrounding medium favors interactions with the core. upon a change in ph, modification in the ionization state of the core will decrease the interactions |
08/24/2004 | US6780427 Superoxide dismutase or other antioxidant are directly applied in combination with polymeric hydrogels at local sites of tissue injury to prevent or decrease formation of adhesions and undesirable proliferation of cells |
08/24/2004 | US6780426 Method and apparatus for improved heat controlled administration of pharmaceuticals |
08/24/2004 | US6780425 In situ formation of transdermal delevery system; coating with drug containing cyanoacrylate adhesive liquid or gel and curing |
08/24/2004 | US6780424 Controlled morphologies in polymer drug for release of drugs from polymer films |
08/24/2004 | US6780421 Vaccine composition comprising at least one antigen and adjuvanting amount of 3-beta-(n-(n',n'-dimethylaminoethane)carbamoyl) cholesterol |
08/24/2004 | US6780406 Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene |
08/24/2004 | US6780400 Delivery of antiemetics through an inhalation route |
08/24/2004 | US6780399 Delivery of stimulants through an inhalation route |
08/24/2004 | US6780398 Aqueous nasal formulation |
08/24/2004 | US6780324 Preparation of sterile stabilized nanodispersions |
08/24/2004 | US6780171 Intradermal delivery device |
08/24/2004 | US6780168 Substance delivery device |
08/24/2004 | CA2323213C Treatment of respiratory disease and otitis media |
08/24/2004 | CA2201784C Method and formulation of stimulating nitric oxide synthesis |
08/24/2004 | CA2178473C Flunisolide aerosol formulations |
08/24/2004 | CA2083651C Redispersible powder composed of n-vinylpyrrolidone/vinyl acetate copolymer, the preparation and use thereof |
08/19/2004 | WO2004070995A2 System and method for medical device authentication |
08/19/2004 | WO2004070994A2 Wireless medical data communication system and method |
08/19/2004 | WO2004070562A2 System and method for notification and escalation of medical data alerts |
08/19/2004 | WO2004070557A2 Method and system for medical device connectivity |
08/19/2004 | WO2004070556A2 Method and system for integrating data flows |
08/19/2004 | WO2004070549A2 Separation of validated information and functions in a healthcare system |
08/19/2004 | WO2004070548A2 System and method for verifying medical device operational parameters |
08/19/2004 | WO2004070546A2 Medical data communication notification and messaging system and method |
08/19/2004 | WO2004070085A1 Dual electrode advanced electrochemical delivery system |
08/19/2004 | WO2004070044A1 Biologically-active-molecule-enriched photosynthetic micro-organisms, preparation method thereof and uses of same |
08/19/2004 | WO2004070019A2 Membrane active polymers |
08/19/2004 | WO2004070017A2 Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
08/19/2004 | WO2004070009A2 Targeted multivalent macromolecules |
08/19/2004 | WO2004069888A2 Block copolymers |
08/19/2004 | WO2004069862A1 Peptide conjugate |
08/19/2004 | WO2004069822A1 Composition for inhibiting steroid side effect |
08/19/2004 | WO2004069323A1 Hemorrhoid treatment anmd method of manufacturing the same |
08/19/2004 | WO2004069294A1 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |
08/19/2004 | WO2004069291A2 Instrument for assisting in the remote placement of tied surgical knots and trimming of suture away from the knot and method of use |
08/19/2004 | WO2004069286A2 Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof |
08/19/2004 | WO2004069284A2 Ultrasound contrast agents and process for the preparation thereof |
08/19/2004 | WO2004069277A1 Stable dispersion of solid particles comprising a water-insoluble pyrazine compound |
08/19/2004 | WO2004069253A1 Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones |
08/19/2004 | WO2004069247A1 Topical immunotherapy and compositions for use therein |
08/19/2004 | WO2004069242A1 Anthelmintic composition |
08/19/2004 | WO2004069234A1 Pharmaceutical compositions and process of production thereof |